Literature DB >> 32674815

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2.

James L Rudolph1, Christopher W Halladay2, Malisa Barber2, Kevin W McConeghy2, Vince Mor3, Aman Nanda4, Stefan Gravenstein5.   

Abstract

OBJECTIVES: Many nursing home residents infected with SARS-CoV-2 fail to be identified with standard screening for the associated COVID-19 syndrome. Current nursing home COVID-19 screening guidance includes assessment for fever, defined as a temperature of at least 38.0°C. The objective of this study was to describe the temperature changes before and after universal testing for SARS-CoV-2 in nursing home residents.
DESIGN: Cohort study. SETTING AND PARTICIPANTS: The Veterans Administration (VA) operates 134 Community Living Centers (CLC), similar to nursing homes, that house residents who cannot live independently. VA guidance to CLCs directed daily clinical screening for COVID-19 that included temperature assessment. MEASURES: All CLC residents (n = 7325) underwent SARS-CoV-2 testing. We report the temperature in the window of 14 days before and after universal SARS-CoV-2 testing among CLC residents. Baseline temperature was calculated for 5 days before the study window.
RESULTS: SARS-CoV-2 was identified in 443 (6.0%) residents. The average maximum temperature in SARS-CoV-2-positive residents was 37.66 (0.69) compared with 37.11 (0.36) (P = .001) in SARS-CoV-2-negative residents. Temperatures in those with SARS-CoV-2 began rising 7 days before testing and remained elevated during the 14-day follow-up. Among SARS-CoV-2-positive residents, only 26.6% (n = 118) met the fever threshold of 38.0°C during the survey period. Most residents (62.5%, n = 277) with confirmed SARS-CoV-2 did experience 2 or more 0.5°C elevations above their baseline values. One cohort of SARS-CoV-2 residents' (20.3%, n = 90) temperatures never deviated >0.5°C from baseline. CONCLUSIONS AND IMPLICATIONS: A single screening for temperature is unlikely to detect nursing home residents with SARS-CoV-2. Repeated temperature measurement with a patient-derived baseline can increase sensitivity. The current fever threshold as a screening criteria for SARS-CoV-2 infection should be reconsidered. Published by Elsevier Inc.

Entities:  

Keywords:  Infection; nursing home; temperature

Mesh:

Year:  2020        PMID: 32674815      PMCID: PMC7280121          DOI: 10.1016/j.jamda.2020.06.009

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


Older people with chronic illness are at greatest risk for severe COVID-19 outcomes. In early March 2020, 34 (33.7%) of 101 SARS-CoV-2infected residents died in a 130-bed Washington State King County nursing home facility; overall mortality was 18%. A total of 50 of 170 health care personnel were infected, along with 16 visitors. These findings led to aggressive monitoring to detect disease, and to efforts to reduce transmission by keeping visitors and symptomatic staff out of the building, while isolating residents in whom COVID-19 was suspected or confirmed. However, of 76 residents with SARS-CoV-2 laboratory-confirmed infection, 57% were asymptomatic, suggesting that symptomatic monitoring will fail to provide timely disease detection and undermine effective outbreak control. Because threshold symptoms and signs, such as a temperature of at least 38.0°C, have been used to determine who is tested, their frequency may underestimate SARS-CoV-2 population prevalence. Standard screening processes now routinely screen for COVID-19 by assessing for temperature >38.0°C. From the King County experience, , “fever” is limited as a screening criterion for COVID-19 in nursing facilities. Although the utility of fever as an indicator has been debated for older adults, , studies have reported that nursing home residents with pneumonia often present without fever , and have a lower basal temperature than community-dwelling older adults. The “older and colder” adage for nursing home residents may have statistical validity but poses challenges in guiding nursing facilities about fever during a pandemic. Although COVID and pneumonia can elevate temperature from within an individual's usual range, an absolute, universal cutoff for fever may miss potentially important temperature perturbations. With infection control practices presently dependent on a threshold temperature criterion to determine fever, we need to better understand the value and limitations such a threshold adds to identifying people infected with SARS-CoV-2 or appropriate actions for additional screening, especially in a nursing home context. We hypothesized that most residents of Veterans Administration Community Life Centers (CLCs) infected with SARS-CoV-2 do have temperature elevations well ahead of a confirmatory test, but also that peak temperatures will not typically meet the current screening criterion threshold of 38°C that follows the Centers for Disease Control and Prevention's (CDC) guidance. ,

Methods

This study was approved by the Providence Veterans Administration Medical Center's Institutional Review Board.

Setting and Context

The VA Healthcare System (VHA) owns and operates 134 CLCs, providing a nursing home environment that serves 8800 veterans on a daily basis. The recognition of COVID-19's emerging risk specific to veterans in CLCs drove a decision by the VHA to try to systematically identify, isolate, and care for CLC veterans with asymptomatic SARS-CoV-2 infection or COVID-19. On March 10, 2020, the VHA issued isolation and temperature guidance to CLCs, including daily monitoring of temperature. On April 14, 2020, VHA guidance required 1-time universal SARS-CoV-2 testing of all CLC residents and staff. The purpose of this analysis was to compare temperature trends and identify maximum temperatures in nursing home residents 14 days before and after systematic testing for SARS-CoV-2 throughout VHA CLCs.

Cohort

Using VHA electronic records, we identified veterans residing in CLCs during the period of March 1, 2020 until May 4, 2020. Veterans who were not tested for COVID-19 were excluded, as were those tested before admission to the CLC. In addition, we excluded those who were symptomatically tested because of symptoms before universal testing. Demographic descriptors were collected from the electronic medical records.

Temperature Measurement

Each CLC uses standard equipment to measure temperature, and enters the reading into the electronic medical record. In most CLCs, temperature is uploaded directly to the electronic medical record from the vital signs machine. Based on CDC guidance, the fever threshold was established at 38.0° C. , For this analysis, we selected the first temperature after 4 am for analysis. We assessed temperatures in the 2 weeks before and after SARS-CoV-2 testing. To establish a baseline temperature for each resident, we calculated the mean of 5 temperatures before our window of interest.

COVID-19 Measurement

We identified SARS-CoV-2 polymerase chain reaction (PCR) testing results from the VA's electronic medical records. The VHA developed a harmonized definition of SARS-CoV-2 test results, requiring a PCR test from a certified laboratory.

Statistics

Those with reverse-transcriptase PCR–confirmed SARS-CoV-2 infection and those without were compared graphically and statistically. Continuous variables were confirmed with a Student's t-test; categorical variables were compared with χ2. Missing temperature data are described in online Supplementary Material 1. Analyses were performed in R 3.6.1; plots were created with the ggplot2 package.

Role of the Funder

The funder had no role in the design, data collection, analysis, interpretation, or writing of this study.

Results

The cohort consisted of veterans (n = 7325) residing in CLCs. A total of 453 (6.0%) veterans tested positive for SARS-CoV-2. Those in whom SARS-CoV-2 was confirmed were older (76.2 vs. 74.2 years, P < .001) than those with negative results (Table 1 ). Racial differences were small and without statistically significant differences. SARS-CoV-2–positive residents had a higher maximum temperature (37.7 vs. 37.1°C, P < .001). In both cohorts, the baseline temperature was 36.6°C (SD ± 0.2) and a temperature deviation of 2 SD is approximately 0.5°C.
Table 1

Baseline Characteristics of Population

Mean (SD), n (%)
P value
SARS-CoV-2+SARS-CoV-2−
N4436882
Age, y76.3 (10.8)74.2 (10.9)<.001
Sex
 Male432 (97.5%)6605 (96.0%).085
 Female11 (2.5%)277 (4.0%)
Race.084
 White286 (64.56%)4724 (68.64%)
 Black123 (27.77%)1593 (23.15%)
 Other races34 (7.67%)565 (8.21%)
Comorbidities
 Obesity101 (22.8%)1913 (27.8%).026
 Hypertension309 (69.8%)4805 (69.8%)1.00
 Heart failure102 (23.0%)1865 (27.1%).069
 Lung disease142 (32.0%)2525 (36.7%).056
 Diabetes165 (37.2%)2780 (40.4%).208
 Dementia301 (68.0%)4298 (62.4%).023
Temperature
 Maximum, °C37.66 (0.69)37.11 (0.36)<.001
 Any fever118 (26.64%)201 (2.92%)<.001
Baseline temperature, °C
 Average36.59 (0.21)36.56 (0.24).001

During 29-day analytic window surrounding SARS-CoV-2 testing.

Five-day window before the analytic window.

Baseline Characteristics of Population During 29-day analytic window surrounding SARS-CoV-2 testing. Five-day window before the analytic window. Figure 1 illustrates the first daily temperatures of those with and without SARS-CoV-2 infection. Residents with confirmed SARS-CoV-2 infection had statistically if not clinically significant temperature elevations beginning 7 days before COVID testing. The highest temperature in the SARS-CoV-2+ group peaked on the day of testing (37.0 ± 0.6°C) at which time 28 (6.3%) of these residents met the CDC-guided 38.0°C fever criterion. During the 14 days of follow-up, the average temperature in those with SARS-CoV-2+ test did not fall within 0.1°C of the group without SARS-CoV-2 infections.
Fig. 1

Temperature in nursing home residents with and without SARS-CoV-2. The graph depicts daily temperature before (negative days) and after (positive days) the testing for SARS-CoV-2 (T0). The shaded area represents the 95% confidence intervals.

Temperature in nursing home residents with and without SARS-CoV-2. The graph depicts daily temperature before (negative days) and after (positive days) the testing for SARS-CoV-2 (T0). The shaded area represents the 95% confidence intervals. Figure 2 centers the maximum temperature (Tmax) during the 2 weeks preceding and following the SARS-CoV-2 testing. Among those with confirmed SARS-CoV-2, those (n = 118, 26.6%) who mounted a Tmax ≥38.0°C had higher temperatures during the entire 4-week window. Those with SARS-CoV-2 in the lowest Tmax quartile had the least temperature variation. The CDC fever threshold of 38°C was not met by 73.4% of residents during the study window. Supplemental Table 1 lists single timepoint temperature screening thresholds.
Fig. 2

Temperature trends according to maximum temperature. This compares daily temperatures relative to the maximum temperature. T0 is defined as the day of maximum temperature. SARS-CoV-2 groups are defined as those who are able to mount a maximum temperature of ≥38.0°C, the lowest quartile, and the remainder. The shaded area represents the 95% confidence intervals.

Supplemental Table 1

Temperature Cutoffs and SARS-CoV-2

Mean (SD), n (%)
SARS-CoV-2+SARS-CoV-2−
N443 (100.00%)6882 (100.00%)
Average baseline temperature36.59 (0.21)36.56 (0.24)
Minimum baseline temperature36.31 (0.26)36.25 (0.31)
Maximum baseline temperature36.90 (0.31)36.87 (0.29)
No change from Baseline421 (95.03%)6682 (97.09%)
Increase 0.1°C from baseline419 (94.58%)6511 (94.61%)
Increase 0.2°C from baseline414 (93.45%)6152 (89.39%)
Increase 0.3°C from baseline400 (90.29%)5438 (79.02%)
Increase 0.4°C from baseline381 (86.00%)4396 (63.88%)
Increase 0.5°C from baseline353 (79.68%)3417 (49.65%)
Increase 0.6°C from baseline319 (72.01%)2479 (36.02%)
Increase 0.7°C from baseline288 (65.01%)1761 (25.59%)
Increase 0.8°C from baseline251 (56.66%)1226 (17.81%)
Increase 0.9°C from baseline222 (50.11%)858 (12.47%)
Increase 1.0°C from baseline192 (43.34%)623 (9.05%)
Increase 1.1°C from baseline172 (38.83%)459 (6.67%)
Increase 1.2°C from baseline141 (31.83%)334 (4.85%)
Increase 1.3°C from baseline122 (27.54%)260 (3.78%)
Increase 1.4°C from baseline107 (24.15%)207 (3.01%)
Increase 1.5°C from baseline92 (20.77%)162 (2.35%)
Increase 1.6°C from baseline85 (19.19%)136 (1.98%)
Increase 1.7°C from baseline77 (17.38%)110 (1.60%)
Increase 1.8°C from baseline64 (14.45%)92 (1.34%)
Increase 1.9°C from baseline56 (12.64%)78 (1.13%)
Increase 2.0°C from baseline51 (11.51%)64 (0.93%)
Tmax ≥36.5°C442 (99.77%)6777 (98.47%)
Tmax ≥37.0°C390 (88.04%)4678 (67.97%)
Tmax ≥37.5°C229 (51.69%)742 (10.78%)
Tmax ≥38.0°C118 (26.64%)201 (2.92%)
Tmax ≥38.5°C60 (13.54%)83 (1.21%)

Tmax, maximum temperature.

Temperature trends according to maximum temperature. This compares daily temperatures relative to the maximum temperature. T0 is defined as the day of maximum temperature. SARS-CoV-2 groups are defined as those who are able to mount a maximum temperature of ≥38.0°C, the lowest quartile, and the remainder. The shaded area represents the 95% confidence intervals. Measurement of temperature deviation from baseline has been proposed as a mechanism to detect underlying infectious disease in nursing home residents. Most residents (79.7%, n = 353) with confirmed SARS-CoV-2 did experience a 0.5°C elevation of their baseline values, and this elevation was noted at least twice in 62.5% (n = 277) (Table 2 ). Figure 3 examines potential temperature change from baseline values (0°C to 2.5°C) occurring more than once (Figure 3A) and more than twice (Figure 3B). Using a threshold increase from baseline occurring in multiple readings offers a favorable balance of sensitivity and specificity relative to a single reading.
Table 2

Repeated Temperature Elevation Among Maximum Temperature Quartiles of SARS-CoV-2+

NTemperature Readings Above Criteria
≥1n (%)≥2n (%)≥3n (%)≥4n (%)
Temperature change of 0.5°C from baseline
 SARS-CoV-2−68823417 (49.6)2052 (29.8)1326 (19.3)905 (13.2)
 SARS-CoV-2+ Tmax quartile
 Lowest10733 (30.8)21 (19.6)15 (14.0)6 (5.6)
 2nd115104 (90.4)67 (58.3)48 (41.7)30 (26.1)
 3rd113111 (98.2)92 (81.4)75 (66.4)58 (51.3)
 Highest108105 (97.2)97 (89.8)83 (76.8)71 (65.7)

Tmax, maximum temperature.

Fig. 3

Change from baseline thresholds in SARS-CoV-2. (A) Percentage of the population that attains 1 or more change(s) from baseline. (B) Those with 2 or more changes from baseline. A reference line is drawn at 0.5°C change.

Repeated Temperature Elevation Among Maximum Temperature Quartiles of SARS-CoV-2+ Tmax, maximum temperature. Change from baseline thresholds in SARS-CoV-2. (A) Percentage of the population that attains 1 or more change(s) from baseline. (B) Those with 2 or more changes from baseline. A reference line is drawn at 0.5°C change.

Discussion

We describe peak and daily morning temperature variation 2 weeks before and after COVID-19 testing among VA CLC residents and the Tmax occurring during that interval. The morning temperatures in CLC residents with SARS-CoV-2 typically began rising a week or more before reaching Tmax. Most residents (74%) did not reach a peak temperature over 38.0°C. The temperature for those with SARS-CoV-2 whose Tmax was at least 0.5°C higher from baseline generally remained elevated for the 14 days of follow-up. Current guidance from the CDC focuses on temperature monitoring for COVID-19 surveillance. , Although fever adds specificity for COVID-19 screening, fever of 38.0°C has not been reliably present, even for those reporting to the hospital; only 42% have met the CDC fever criterion. A fever threshold definition of 38.0°C can serve as an excellent proxy for underlying COVID-19 population prevalence, but such a threshold lacks sensitivity for surveillance purposes when applied to a nursing home population. Such a high threshold can delay early recognition of the need for and implementation of systematic testing and additional life-saving infection control measures for frail, older nursing residents. Most (62.5%, n = 277) CLC residents with SARS-CoV-2 have at least 2 deviations from baseline of 0.5°C, which is more sensitive and specific than an absolute threshold of 38°.0C. As a result, the current fever threshold as a screening criterion for SARS-CoV-2 infection should be reconsidered. This is the latest in a string of literature that describes substantial variability in baseline vital signs among older people.7, 8, 9 With the use of electronic health records (EHRs) that store vital signs, including temperature, we can establish a personalized baseline temperature range for the older nursing facility resident, , thus allowing the record EHR system to alert staff when a resident's temperature exceeds this range. It is time to assess if an EHR alert of out-of-range temperatures can improve disease surveillance and result in earlier interventions in general, if not specifically for COVID-19. The strengths of this analysis include the robust nursing home sample, the near universal monitoring of COVID-19, and the daily monitoring of temperature. These data collections allow for the construction of a more comprehensive picture of temperature and vital signs and can also inform decisions for SARS-CoV-2 testing and follow-up. We note 2 important limitations. First, we have not distinguished sensitivity of temperature thresholds for SARS-CoV-2 detection when separated between individuals who have met other symptom screening criteria from those who do not. However, the systematic approach by the VHA to perform national testing and the exclusion of individuals with known COVID-19 suggest that the vast majority of these individuals were asymptomatic at the time of testing. Second, the findings may not be generalizable to an older population as a whole because our sample is limited to one that is predominantly male with extensive comorbidities. The universal screening provided an important measurement structure, but limits our knowledge of which residents might have been screened otherwise.

Conclusions and Implications

Most older nursing home residents do have temperature elevations when infected with SARS-CoV-2, but this elevation infrequently meets a fever threshold 38.0°C. Lower temperature excursions, such as 0.5°C, can improve sensitivity and recurrent excursions specificity for SARS-CoV-2 infection. Consideration of triggering COVID-19 screening based on an excursion threshold from a personalized temperature range may lead to earlier recognition of COVID-19 activity in a long-term care setting.
  9 in total

1.  Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America.

Authors:  Kevin P High; Suzanne F Bradley; Stefan Gravenstein; David R Mehr; Vincent J Quagliarello; Chesley Richards; Thomas T Yoshikawa
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

2.  Role of body temperature in diagnosing bacterial infection in nursing home residents.

Authors:  Philip D Sloane; Christine Kistler; C Madeline Mitchell; Anna S Beeber; Rosanna M Bertrand; Alrick S Edwards; Lauren E W Olsho; Louise S Hadden; James R Bateman; Sheryl Zimmerman
Journal:  J Am Geriatr Soc       Date:  2014-01       Impact factor: 5.562

3.  The significance of pneumonia in the elderly.

Authors:  G Rosenberg
Journal:  Can Fam Physician       Date:  1987-05       Impact factor: 3.275

4.  Control of Communicable Diseases. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2017-01-19

5.  Fever response in elderly nursing home residents: are the older truly colder?

Authors:  S C Castle; D C Norman; M Yeh; D Miller; T T Yoshikawa
Journal:  J Am Geriatr Soc       Date:  1991-09       Impact factor: 5.562

6.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

7.  Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.

Authors:  Anne Kimball; Kelly M Hatfield; Melissa Arons; Allison James; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Zeshan Chisty; Jeneita M Bell; Mark Methner; Josh Harney; Jesica R Jacobs; Christina M Carlson; Heather P McLaughlin; Nimalie Stone; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Denny Russell; Brian Hiatt; Jessica Gant; Jeffrey S Duchin; Thomas A Clark; Margaret A Honein; Sujan C Reddy; John A Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

8.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

9.  Spread of SARS-CoV-2 in the Icelandic Population.

Authors:  Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-04-14       Impact factor: 91.245

  9 in total
  10 in total

1.  Health impact of the first and second wave of COVID-19 and related restrictive measures among nursing home residents: a scoping review.

Authors:  Marjolein E A Verbiest; Annerieke Stoop; Aukelien Scheffelaar; Meriam M Janssen; Leonieke C van Boekel; Katrien G Luijkx
Journal:  BMC Health Serv Res       Date:  2022-07-15       Impact factor: 2.908

2.  Impact of fever thresholds in detection of COVID-19 in Department of Veterans Affairs Community Living Center residents.

Authors:  Taissa Bej; Sonya Kothadia; Brigid M Wilson; Sunah Song; Janet M Briggs; Richard E Banks; Curtis J Donskey; Federico Perez; Robin L P Jump
Journal:  J Am Geriatr Soc       Date:  2021-09-04       Impact factor: 7.538

3.  Is It Useful to Determine the Temperature of Children for COVID-19 Screening in the Dental Setting?

Authors:  Eliane García-Mato; Iván Varela-Aneiros; Maite Abeleira-Pazos; Mercedes Outumuro-Rial; Pedro Diz-Dios; Jacobo Limeres-Posse; Márcio Diniz-Freitas
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

4.  The Italian national survey on Coronavirus disease 2019 epidemic spread in nursing homes.

Authors:  Flavia L Lombardo; Ilaria Bacigalupo; Emanuela Salvi; Eleonora Lacorte; Paola Piscopo; Flavia Mayer; Antonio Ancidoni; Giulia Remoli; Guido Bellomo; Gilda Losito; Fortunato D'Ancona; Antonio Bella; Patrizio Pezzotti; Marco Canevelli; Graziano Onder; Nicola Vanacore
Journal:  Int J Geriatr Psychiatry       Date:  2021-01-02       Impact factor: 3.850

5.  The Winter Respiratory Viral Season During the COVID-19 Pandemic.

Authors:  Christine E Kistler; Robin L P Jump; Philip D Sloane; Sheryl Zimmerman
Journal:  J Am Med Dir Assoc       Date:  2020-10-26       Impact factor: 4.669

6.  Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis.

Authors:  Mohammad Rashidul Hashan; Nicolas Smoll; Catherine King; Hannah Ockenden-Muldoon; Jacina Walker; Andre Wattiaux; Julieanne Graham; Robert Booy; Gulam Khandaker
Journal:  EClinicalMedicine       Date:  2021-03-01

7.  Wearable sensor derived decompensation index for continuous remote monitoring of COVID-19 diagnosed patients.

Authors:  Dylan M Richards; MacKenzie J Tweardy; Steven R Steinhubl; David W Chestek; Terry L Vanden Hoek; Karen A Larimer; Stephan W Wegerich
Journal:  NPJ Digit Med       Date:  2021-11-08

8.  Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update.

Authors:  Adam H Dyer; Aoife Fallon; Claire Noonan; Helena Dolphin; Cliona O'Farrelly; Nollaig M Bourke; Desmond O'Neill; Sean P Kennelly
Journal:  J Am Med Dir Assoc       Date:  2022-07-04       Impact factor: 7.802

9.  Can we use temperature measurements to identify pre-symptomatic SARS-CoV-2 infection in nursing home residents?

Authors:  Salaheldin Elhamamsy; Frank DeVone; Thomas Bayer; Chris Halladay; Marilyne Cadieux; Kevin McConeghy; Ashna Rajan; Moniyka Sachar; Nadia Mujahid; Mriganka Singh; Aman Nanda; Lynn McNicoll; James L Rudolph; Stefan Gravenstein
Journal:  J Am Geriatr Soc       Date:  2022-08-04       Impact factor: 7.538

10.  Can we clinically identify pre-symptomatic and asymptomatic COVID-19?

Authors:  Salaheldin Elhamamsy; Frank DeVone; Tom Bayer; Chris Halladay; Marilyne Cadieux; Kevin McConeghy; Ashna Rajan; Moniyka Sachar; Nadia Mujahid; Aman Nanda; Lynn McNicoll; James L Rudolph; Stefan Gravenstein
Journal:  medRxiv       Date:  2021-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.